Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel

Infection and Immunity

Volumn 69, Issue 3, 2001, Pages 1351-1357

  Passwell, J H ^a   Harlev, E ^a   Ashkenazi, S ^a   Chu, C ^a   Miron, D ^a   Ramon, R ^a   Farzan, N ^a   Shiloach, J ^a   Bryla, D A ^a   Majadly, F ^a   Roberson, R ^a   Robbins, J B ^a   Schneerson, R ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPIC ACID DERIVATIVE; BACTERIAL POLYSACCHARIDE; CARRIER PROTEIN; DIPHTHERIA TOXIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; O ANTIGEN; POLYSACCHARIDE VACCINE; PSEUDOMONAS EXOTOXIN; SHIGELLA VACCINE; SUCCINIC ANHYDRIDE;

ADULT; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CONJUGATE; CONTROLLED STUDY; CORYNEBACTERIUM DIPHTHERIAE; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; DYSENTERY, BACILLARY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ISRAEL; MALE; O ANTIGENS; SHIGELLA VACCINES; VACCINES, CONJUGATE;

EID: 0035115549     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.3.1351-1357.2001     Document Type: Article

References (58)

1. Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197
2. Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197
3. Convulsions in childhood shigellosis. Clinical and laboratory features in 153 children
4. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children
5. Antibodies to lipopolysaccharide after immunization of humans with rough mutant Escherichia coli
6. Epidemiological analysis of the duration of intestinal immunity after natural infection with Shigella
7. Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh
8. New method for quantitative determination of uronic acids
9. Are diarrhoea programmes likely to reduce childhood malnutrition? Observations from Bangladesh
10. Further studies on immunogenicity of Haemophilus influenzae type b and pneumococcal 6A polysaccharide-protein conjugates
11. Serum antibodies to lipopolysaccharide and natural immunity to Shigellosis in an Israeli military population
12. Safety and immunogenicity of investigational Shigella conjugate vaccines in Israeli volunteers
13. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections
14. A prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis
15. Double-blind vaccine-controlled randomized efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults
16. The epidemiology of shigellosis in Israel
17. Immunization with rough mutants of Salmonella minnesota: Initial studies in human subjects
18. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection
19. Shigella and enteroinvasive Escherichia coli infections in households of children with dysentery in Bangkok
20. Shigella flexneri O-antigen specific enzyme immunoassay: A prospective study of class-specific antibody titres against lipopolysaccharide antigens in Vietnamese children and adults with serotype 1b or 2a dysentery
21. Shigella flexneri O-antigen-specific immunoassay: Class-specific antibody titres against lipopolysaccharide antigens in healthy Vietnamese and Swedish populations
22. Synthesis and immunologic properties in mice of vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides conjugated to Pseudomonas aeruginosa recombinant exoprotein A
23. Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile
24. The measurment of amino groups in proteins and peptides
25. Failure of parenteral vaccines to protect monkeys against experimental shigellosis
26. Existing status of shigellois in Andaman & Nicobar Islands
27. Succinylation of pepsinogen
28. Four decades of shigellosis in Israel - The epidemiology of a growing public health problem
29. Phase 1 evaluation of Vibrio cholerae O1, serotype Inaba, polysaccharide-cholera toxin conjugates in adult volunteers
30. Dysentery, not watery diarrhoea, is associated with stunting in Bangladeshi children
31. Studies in volunteers to evaluate candidate Shigella vaccines: Further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease
32. Studies in shigellosis. III. A controlled evaluation of a monovalent Shigella vaccine in a highly endemic environment
33. A method for the quantitative modification and estimation of carboxylic acid groups in proteins
34. Single mutation in the A domain of diphtheria toxin results in a protein with altered membrane insertion behavior
35. Immunoglobulin subclass distribution and dynamics of Shigella-specific antibody responses in serum and stool samples in shigellosis
36. Synthesis, characterization and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid, with emphasis on the role of O-acetyls
37. Investigational vaccine for Escherichia coli O157: Phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A (rEPA) conjugates in adults
38. Global burden of Shigella infections: Implications for vaccine development and implementation of control strategies
39. Relationship between humoral immune responses and oral temperature during human shigellosis
40. Purification and some properties of a verotoxin from a human strain of Escherichia coli that is immunologically related to Shiga-like toxin II (VT2)
41. Shigella lipopolysacchride antibodies in pediatric populations
42. Treatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in mice
43. Clostridium difficile recombinant toxin A repeating units as a carrier protein for conjugate vaccines: Studies of pneumococcal type 14. Escherichia coli K1, and Shigella flexneri type 2a polysaccharides in mice
44. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type .1
45. Hypothesis for vaccine development: Protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides
46. Perspective: Hypothesis: Serum IgG antibody is sufficient to confer protection against infectious disease by inactivating the inoculum
47. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b: Impact on public health and implications for other polysaccharide-based vaccines
48. Diagnosis and management of dysentery, by community health workers
49. Preparation. Characterization and immunogenicity of Haenophilus influenzae type b polysaccharide-protein conjugates
50. Stabilization of tetanus and diphtheria toy oids against moisture-induced aggregation
51. Determination of protein-bound carbohydrate by an anthrone method
52. Ueber den dysenteriebacillus (Bacillus dysenteriae)
53. The combined use of expanded bed volume adsorption and gradient elution for capture and partial purification of mutant diphtheria toxin (CRM9) from Corynebacterium diphtheriae
54. The role of Shigella spp., enteroinvasive Escherichia coli, and other enteropathogens as causes of childhood dysentery in Thailand
55. Clinical and microbiological features of Shigella and enteroinvasive Escherichia coli infections detected by DNA hybridization
56. Synthesis, characterization and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids